CMK389

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CMK389, covering 2024-05-09 to 2024-10-02. Get the full timeline:

Most recent: Clinical Trial Update: Study of Efficacy, Safety and Tolerability of CMK389 in Patients With Chronic Pulmonary Sarcoidosis [Phase 2]